Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity.
Cho H, Lee E, Kim J, Shin S, Kim YJ, Lee H, Yu JH, Jeon YH, Lee SW, Lee SY, Park KW, Kang JS, Kwon SH, Kim Y, Jeon R.
Cho H, et al. Among authors: yu jh.
Eur J Pharm Sci. 2024 Sep 30;203:106921. doi: 10.1016/j.ejps.2024.106921. Online ahead of print.
Eur J Pharm Sci. 2024.
PMID: 39357770
Free article.